ACTIVATE in Public Housing

Completed · Not applicable

Conditions studied: Pneumonia, Influenza, Varicella Zoster, Meningitis, COVID-19, Vaccine Hesitancy

In brief

This multilevel, multidisciplinary, theoretically based, culturally sensitive, community-engaged intervention sets out to mitigate uptake barriers and non-adherence to vaccination schedules as recommended by the CDC and increase influenza, meningitis, pneumonia, VZV, and COVID-19 vaccine rates among under-resourced African American and Latino public housing residents in South Los Angeles.

Key facts

Study ID

NCT06075732

Run by

Charles Drew University of Medicine and Science

People needed

400

Starts

2024-07-01

Expected to finish

2024-12-02

Last updated by the study team

2025-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• identify as Latinx or African American
• age 18 or older
• reside in one of the six collaborating public housing area
• Speak either English or Spanish
• Report vaccine hesitancy

You may not qualify if…

• Not a resident at one of the collaborating public housing areas
• Does not self-identify as African American or Latinx
• Age 17 and younger
• Unable to speak either English or Spanish
• Received all recommended vaccines for Influenza, Pneumonia, Meningitis, VZV, and COVID-19
• No reporting of vaccine hesitancy

Where it is running

• Charles R. Drew University of Medicine & Science — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.